Loading Events

« All Events

  • This event has passed.

International Conference on Viral Hepatitis (ICVH 2017)

October 9, 2017 - October 10, 2017

ICVH 2017

Click here to register online for ICVH 2017.

The 2017 International Conference on Viral Hepatitis (ICVH 2017) will take place October 9-10, 2017, at the Gleacher Center in Chicago. ICVH 2017 is sponsored by the International Association of Providers of AIDS Care (IAPAC), in partnership with the Alliance to Eliminate HIV/HCV Coinfection (AEH2C).

The conference Co-Chairs are Nancy Reau, MD (Rush University Medical Center, Chicago, IL, USA) and Vicente Soriano, MD, PhD (Hospital Carlos III, Madrid, Spain).

Confirmed faculty as of July 14, 2017, include: Kosh Agarwal, MD (King’s College Hospital, London, England); Sanjeev Arora, MD (University of New Mexico, Albuquerque, NM, USA); Michael Charlton, MBBS (Intermountain Transplant and Regenerative Medicine Center, Salt Lake City, UT, USA); Daniel Fierer, MD (Icahn School of Medicine at Mount Sinai, New York, NY, USA); Donald M. Jensen, MD (Rush University Medical Center, Chicago, IL, USA); Natasha Martin, DPhil (University of California, San Diego, CA, USA); Mark Nelson, MD (Chelsea & Westminster Hospital, London, England); Robert Perillo, MD (Baylor University Medical Center, Dallas, TX, USA); Fred Poordad, MD (University of Texas, San Antonio, San Antonio, TX, USA); Kenneth Sherman, MD, PhD (University of Cincinnati, OH, USA); Wendy Spearman, MBChB, MMed, PhD (University of Cape Town, South Africa); Helen S. Te, MD (University of Chicago, IL, USA); Stacy Trooskin, MD (Philadelphia FIGHT Health Centers, Philadelphia, PA, USA); and John Ward, MD (Centers for Disease Control and Prevention, Atlanta, GA, USA).

Featured topics on the ICVH 2017 program will include:

  • HBV and HCV Elimination – The Importance of Modeling
  • New HBV Therapeutic Perspectives and Options
  • HBV Reactivation – Who, When, How?
  • Casting a Wider Net to Integrate HCV Care into Primary Care
  • Myth Busters – Do DAAs Cause HCC? Reactivate HBV?
  • HCV Mechanisms of Sexual Transmission – What Do We Know?
  • Acute HCV and its Treatment: Improving Symptoms, Preventing Transmission
  • Beyond Cure – Dissecting the HCV Standard of Care
  • Resistance to DAAs – Do We Need More HCV Treatment Options?
  • Does HCV Therapy with DAAs Prevent or Simply Delay Liver Transplants?
  • NASH: The New Epidemic in HIV-Coinfected Patients?
  • TAF and HBV/HIV Coinfection – Who, When, How?
  • HCV Coinfection – Can We Eliminate HCV without a Focus on MSM?

The conference’s target audience includes liver specialists (hepatologists and gastroenterologists) and infectious disease (ID) and non-ID-specialized physicians, nurses, and pharmacists.

Click here to view the ICVH 2017 program, including confirmed/invited faculty.

Online registration is now open. Early Registration is $100 for IAPAC members and $125 for non-IAPAC members. The Early Registration deadline has been extended to August 18, 2017.

Click here to register online for ICVH 2017.



Embassy Suites Chicago Magnificent Mile
511 North Columbus Drive
Chicago, IL 60611 United States
+ Google Map

©2020 HepFree.NYC. All rights reserved. Site by Lookit®


Log in with your credentials

Forgot your details?